Kieger Sustainable Healthcare Fund Class B CHF Accumulating

Reference Data

ISIN LU2488092722
Valor Number 119403767
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class B CHF Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager.
Peculiarities

Fund Prices

Current Price * 96.58 CHF 24.07.2025
Previous Price * 96.20 CHF 23.07.2025
52 Week High * 117.58 CHF 02.09.2024
52 Week Low * 93.48 CHF 21.07.2025
NAV * 96.58 CHF 24.07.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 198,703,065
Unit/Share Assets *** 1,195,554
Trading Information SIX

Performance

YTD Performance -10.97% 31.12.2024
24.07.2025
1 month -1.00% 24.06.2025
24.07.2025
3 months -3.31% 24.04.2025
24.07.2025
6 months -16.17% 24.01.2025
24.07.2025
1 year -17.13% 24.07.2024
24.07.2025
2 years -5.40% 24.07.2023
24.07.2025
3 years -3.42% 20.03.2023
24.07.2025
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.66%
Abbott Laboratories 5.64%
AstraZeneca PLC 5.38%
Novartis AG Registered Shares 5.33%
Roche Holding AG 4.81%
UnitedHealth Group Inc 4.61%
Boston Scientific Corp 3.77%
Vertex Pharmaceuticals Inc 3.66%
Intuitive Surgical Inc 3.42%
Novo Nordisk AS Class B 3.39%
Last data update 30.04.2025

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)